Zeo ScientifiX (ZEOX) Change in Receivables (2016 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Change in Receivables of $214000.0 for Q2 2026, up 4180.0% year-over-year from $5000.0 in Q2 2025, and up 692.59% quarter-over-quarter from $27000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Change in Receivables (2016 - 2026) Analysis & Trends
Zeo ScientifiX's Change in Receivables history runs 11 years deep, the most recent figure standing at $214000.0 for Q2 2026.
- In Q2 2026, Change in Receivables rose 4180.0% year-over-year to $214000.0; the TTM figure through Apr 2026 stood at $265000.0 (up 762.5% YoY), while the FY2025 annual figure was -$159000.0, down 185.95% from the prior year.
- Change in Receivables for Q2 2026 stood at $214000.0, up from $27000.0 in the prior quarter.
- The five-year high for Change in Receivables was $214000.0 in Q2 2026, with the low at -$188000.0 in Q1 2025.
- The 5-year median for Change in Receivables is $6500.0 (2023), against an average of $11825.1.
- Peak annual rise in Change in Receivables reached 6200.0% in 2024, while the deepest fall reached 600.0% in 2024.
- Zeo ScientifiX's Change in Receivables stood at -$43893.0 in 2022, then jumped by 93.17% to -$3000.0 in 2023, then surged by 6200.0% to $183000.0 in 2024, then slumped by 80.87% to $35000.0 in 2025, then jumped by 511.43% to $214000.0 in 2026.
- Business Quant data shows ZEOX's Change in Receivables at $214000.0 in Q2 2026, $27000.0 in Q1 2026, and $35000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 214,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 214,000.00 |
| Apr 30, 2026 | 214,000.00 |
| Jan 31, 2026 | 27,000.00 |
| Jan 31, 2026 | 27,000.00 |
| Oct 31, 2025 | 35,000.00 |
| Oct 31, 2025 | 35,000.00 |
| Jul 31, 2025 | -11,000.00 |
| Jul 31, 2025 | -11,000.00 |
| Apr 30, 2025 | 5,000.00 |
| Apr 30, 2025 | 5,000.00 |
| Jan 31, 2025 | -188,000.00 |
| Jan 31, 2025 | -188,000.00 |
| Oct 31, 2024 | 183,000.00 |
| Oct 31, 2024 | 183,000.00 |
| Jul 31, 2024 | -40,000.00 |
| Jul 31, 2024 | -40,000.00 |
| Apr 30, 2024 | -17,000.00 |
| Apr 30, 2024 | -17,000.00 |
| Jan 31, 2024 | 59,000.00 |
| Jan 31, 2024 | 59,000.00 |